Pacira Pharmaceuticals Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
40.96 M |
Public Float |
39.52 M |
Pacira Pharmaceuticals Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.17 |
Market Cap |
$1.79 B |
Shares Outstanding |
41.3 M |
Public Float |
39.78 M |
Address |
5 Sylvan Way Parsippany New Jersey 07054 United States |
Employees | - |
Website | http://www.pacira.com |
Updated | 07/08/2019 |
Pacira Pharmaceuticals, Inc. is a holding company, which engages in the development, commercialization, and manufacture of pharmaceutical products for use in postsurgical outcomes for acute care practitioners and their patients. Its flagship product, EXPAREL, redefines pain management after surgery as an opioid-free alternative indicated for single-dose infiltration into the surgical site to produce postsurgical analgesia. The company was founded in December 2006 and is headquartered in Parsippany, NJ. |